adagrasib
mirati
['sclc', 'adagrasib', 'nsclc', '$mrtx']
$mrtx up over 27% after presenting adagrasib data showing regression of cns metastases in patients with krasg12c mutated nsclc yesterday at #asco22. first clinical dataset with krasg12c inhibitor in patients w/ untreated cns metastases. 
FDA Catalyst Calendar, Big Mover™ stocks to watch, & Model Portfolios. 

Database & tools to make you a profitable biotech stock investor. Try Free https://t.co/5njnanqtbK